Compare TBPH & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | NPK |
|---|---|---|
| Founded | 2013 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 945.9M |
| IPO Year | 2013 | 1994 |
| Metric | TBPH | NPK |
|---|---|---|
| Price | $16.66 | $129.76 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.40 | N/A |
| AVG Volume (30 Days) | ★ 320.5K | 103.0K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | $15,386,000.00 | ★ $503,524,000.00 |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $132.74 |
| Revenue Growth | N/A | ★ 29.70 |
| 52 Week Low | $10.82 | $91.28 |
| 52 Week High | $21.03 | $149.86 |
| Indicator | TBPH | NPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 49.44 |
| Support Level | $16.07 | $129.08 |
| Resistance Level | $17.21 | $136.51 |
| Average True Range (ATR) | 0.33 | 4.45 |
| MACD | 0.06 | 0.34 |
| Stochastic Oscillator | 79.70 | 67.86 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
National Presto Industries Inc has an electric product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments, namely Defense, Housewares/Small Appliance, and Safety. The defense segment, which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases, performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While the Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances, the safety segment provides safety technology empowering organizations and individuals to protect what is more important.